BlackRock Health Sciences Trust II of Beneficial Interest (BMEZ) Peer Comparison
$17.83
As on 29-Oct-2026 16:00EDT
Market cap
$1,049 Mln
Revenue (TTM)
$-- Mln
P/E Ratio
4.9
P/B Ratio
1
Div. Yield
0 %
| BlackRock Health Sciences Trust II of Beneficial Interest (BMEZ) | FS KKR Capital (FSK) | Tri Continental Closed Fund (TY) | SRH Total Return Fund Inc (STEW) | General American Investors Closed Fund (GAM) | |
|---|---|---|---|---|---|
Market cap ($ Mln) |
1,049 | 2,910 | 1,846 | 1,767 | 1,531 |
Revenue ($ Mln) |
24 | 948 | 205 | 102 | 24 |
Net Profit ($ Mln) |
23.45 | -375.00 | 254.31 | 174.09 | 376.65 |
Net Margin (%) |
-- | -39.56 | -- | -- | 1,542.35 |
RoE (%) |
3.46 | -6.75 | 13.09 | 8.01 | 20.46 |
Price to Earnings |
4.95 | -- | 5.44 | 12.13 | 4.03 |
Price-To-Book |
0.97 | 0.60 | 0.91 | 0.80 | 0.89 |
Income Statement ($ Mln)
| BlackRock Health Sciences Trust II of Beneficial Interest (BMEZ) | FS KKR Capital (FSK) | Tri Continental Closed Fund (TY) | SRH Total Return Fund Inc (STEW) | General American Investors Closed Fund (GAM) | |
|---|---|---|---|---|---|
|
Operating Revenue
|
24.07 | 1,110.00 | 321.66 | 83.37 | 251.67 |
|
Cost of Revenue
|
0.00 | 446.00 | 0.00 | 20.47 | 13.16 |
|
Gross Profit
|
24.07 | 664.00 | 321.66 | 62.90 | 251.67 |
|
Operating Expenses
|
0.62 | 56.00 | 0.91 | 21.43 | 6.22 |
|
Operating Profit (EBIT)
|
0.93 | 608.00 | 320.75 | 553.74 | 245.46 |
|
Other Income
|
-- | -- | -- | -- | -- |
|
Profit before Tax
|
23.45 | 608.00 | 320.75 | 547.43 | 245.46 |
|
Provision for Tax
|
-- | 23.00 | -- | -- | -- |
|
Profit after Tax (Net Income)
|
23.45 | 585.00 | 320.75 | 547.43 | 245.46 |
|
Minority Interest
|
-- | -- | -- | -- | -- |
|
Consolidated Profit
|
-- | 585.00 | -- | -- | -- |
Liabilities ($ Mln)
| BlackRock Health Sciences Trust II of Beneficial Interest (BMEZ) | FS KKR Capital (FSK) | Tri Continental Closed Fund (TY) | SRH Total Return Fund Inc (STEW) | General American Investors Closed Fund (GAM) | |
|---|---|---|---|---|---|
|
Shareholder's Funds
|
768.57 | 6,622.00 | 1,901.37 | 2,118.60 | 1,546.03 |
|
Minority Interest
|
-- | -- | -- | -- | -- |
|
Non-Current Liabilities
|
6.03 | 7,487.00 | 0.56 | 223.55 | 18.22 |
|
Current Liabilities
|
-- | 110.00 | 3.76 | 8.91 | 0.37 |
|
Total Liabilities
|
774.59 | 14,219.00 | 1,905.68 | 2,351.07 | 1,564.62 |
Assets ($ Mln)
| BlackRock Health Sciences Trust II of Beneficial Interest (BMEZ) | FS KKR Capital (FSK) | Tri Continental Closed Fund (TY) | SRH Total Return Fund Inc (STEW) | General American Investors Closed Fund (GAM) | |
|---|---|---|---|---|---|
|
Non-Current Assets
|
773.33 | 13,550.00 | 1,894.76 | 2,349.48 | 1,552.86 |
|
Current Assets
|
26.56 | 669.00 | 10.92 | 86.33 | 11.76 |
|
Total Assets
|
774.59 | 14,219.00 | 1,905.68 | 2,351.07 | 1,564.62 |
|
Total Debt*
|
0.28 | 7,351.00 | 0.01 | 223.55 | 2.40 |
|
Net Current Assets
|
-- | -- | -- | -- | -- |
Cashflow ($ Mln)
| BlackRock Health Sciences Trust II of Beneficial Interest (BMEZ) | FS KKR Capital (FSK) | Tri Continental Closed Fund (TY) | SRH Total Return Fund Inc (STEW) | General American Investors Closed Fund (GAM) | |
|---|---|---|---|---|---|
|
Cash From Operating Activities
|
65.52 | 1,901.00 | -- | 62.50 | -- |
|
Cash Flow from Investing Activities
|
-- | -- | -- | 2.24 | -- |
|
Cash from Financing Activities
|
-65.52 | -1,836.00 | -- | -62.50 | -- |
|
Net Cash Inflow / Outflow
|
-- | -- | -- | -- | -- |
Ratios
Profitability Ratios
| BlackRock Health Sciences Trust II of Beneficial Interest (BMEZ) | FS KKR Capital (FSK) | Tri Continental Closed Fund (TY) | SRH Total Return Fund Inc (STEW) | General American Investors Closed Fund (GAM) | |
|---|---|---|---|---|---|
|
ROCE (%)
|
3.46 | 4.03 | 17.57 | 26.07 | 16.50 |
|
ROE (%)
|
3.46 | 8.69 | 17.57 | 29.18 | 16.53 |
|
ROA (%)
|
3.42 | 3.94 | 17.53 | 26.00 | 16.31 |
|
EBIT Margin (%)
|
-- | -- | -- | -- | -- |
|
Net Margin (%)
|
97.44 | 52.70 | 99.72 | 656.60 | 97.53 |
|
Cash Profit Margin (%)
|
-- | -- | -- | -- | -- |
Growth Ratios
| BlackRock Health Sciences Trust II of Beneficial Interest (BMEZ) | FS KKR Capital (FSK) | Tri Continental Closed Fund (TY) | SRH Total Return Fund Inc (STEW) | General American Investors Closed Fund (GAM) | |
|---|---|---|---|---|---|
|
Revenue Growth (%)
|
1.94 | -0.10 | 0.27 | 0.00 | 1.81 |
|
EBIT Growth (%)
|
-- | -- | -- | -- | -- |
|
Net Profit Growth (%)
|
17.17 | -15.95 | 26.74 | 290.15 | -10.22 |
|
EPS Growth (%)
|
0.23 | -0.16 | 0.25 | -- | -0.41 |
|
Book Value Growth (%)
|
-- | -- | -- | -- | -- |
Valuation Ratios
| BlackRock Health Sciences Trust II of Beneficial Interest (BMEZ) | FS KKR Capital (FSK) | Tri Continental Closed Fund (TY) | SRH Total Return Fund Inc (STEW) | General American Investors Closed Fund (GAM) | |
|---|---|---|---|---|---|
|
Price / Earnings
|
8.14 | 10.40 | 5.26 | -- | 4.88 |
|
Price / Book Value
|
0.25 | 0.92 | 0.89 | -- | 0.77 |
|
Dividend Yield (%)
|
-- | -- | -- | -- | -- |
|
EV/EBITDA
|
177.53 | 21.61 | 5.26 | 0.25 | 4.88 |
|
Market Cap ($ Cr)
|
-- | -- | -- | -- | -- |
Solvency Ratios
| BlackRock Health Sciences Trust II of Beneficial Interest (BMEZ) | FS KKR Capital (FSK) | Tri Continental Closed Fund (TY) | SRH Total Return Fund Inc (STEW) | General American Investors Closed Fund (GAM) | |
|---|---|---|---|---|---|
|
Debt to Equity
|
0.00 | 1.11 | 0.00 | 0.11 | 0.00 |
|
Short term debt to equity ratio
|
0.00 | 0.00 | 0.00 | -- | 0.00 |
|
Current Ratio
|
-- | 6.08 | 2.91 | 9.69 | 31.80 |
|
Quick Ratio
|
-- | -- | -- | -- | -- |
|
Interest Coverage
|
313,228.00 | 4.28 | -- | -- | -- |
Operating Efficiency Ratios
| BlackRock Health Sciences Trust II of Beneficial Interest (BMEZ) | FS KKR Capital (FSK) | Tri Continental Closed Fund (TY) | SRH Total Return Fund Inc (STEW) | General American Investors Closed Fund (GAM) | |
|---|---|---|---|---|---|
|
Debtors to sales (%)
|
4.97 | 33.60 | 3.34 | 1.81 | 4.65 |
|
Asset Turnover
|
0.04 | 0.07 | 0.18 | 0.04 | 0.17 |
|
Receivable days
|
21.03 | 149.56 | 16.23 | 8.90 | 12.71 |
|
Inventory Days
|
-- | 176.07 | -- | -- | -28.01 |
|
Payable days
|
-- | 165.43 | 1,931,335.68 | 7.82 | 27.39 |
|
Cash Conversion Cycle
|
-- | 160.20 | -- | -- | -42.69 |